# Volume 09: Modality-Combination Distribution & Tail-Robustness Analysis

> **Executive Summary**: Comprehensive investigation into how modality combination frequencies impact ACARA-U behavior, routing entropy, and decision-level risk stability across balanced (`D1_BALANCED`), moderate head-tail (`D2_MODERATE_HEAD_TAIL`), and heavy long-tail (`D3_STRONG_LONG_TAIL`) regimes.

---

## 1. Volume Overview & Research Highlights

- **Pre-Registered Distribution Configurations**: 3 controlled frequency distributions across $N=500$ decision packets ($\text{seed}=115$):
  - **D1 (Balanced)**: $P(c) = 1/7 \approx 14.29\%$ per combination ($HTR = \text{N/A}$, no tail).
  - **D2 (Moderate Tail)**: RFC 35%, RF 25%, RC 15%, FC 10%, R 6%, F 5%, C 4% ($HTR = 4.00$).
  - **D3 (Strong Tail)**: RFC 50%, RF 25%, RC 10%, FC 8%, R 4%, F 2%, C 1% ($HTR = 10.71$).
- **Simplex & Safety Verification**: $0$ routing invariant violations over 1,500 trials; active weights strictly normalize to $1.000000$ and inactive channels receive $0.000000$.
- **Observed Tail Sensitivity Comparison Across Soft Baselines**: ACARA-U achieves the lowest point-estimate tail risk deviation ($D_{\text{tail}} = 0.1883$ in D2, $0.1876$ in D3) among evaluated soft-weighting baselines (B2 $0.1925/0.1945$, B3 $0.1959/0.1974$, B4 $0.1967/0.1973$, B5 $0.1889/0.1889$), with a small margin over B5. Winner-take-all B1 achieves lower nominal tail deviation but exhibits higher head-tier risk dispersion ($\sigma = 0.2755$ vs $0.1880$).
- **Fail-Closed Verification**: Zero-modality inputs ($\text{EMPTY}$) unconditionally return `NO_MODALITY_AVAILABLE` with $R_{\text{fusion}} = 0.0$ and $\text{DCRI} = 0.0$.
- **Statistical Rigor**: 1,000-resample non-parametric bootstrap $95\%$ confidence intervals computed for all combinations and metrics.

---

## 2. Chapter Index & Navigation

1. [**01_Combination_Protocol.md**](file:///d:/FusionMedAI/research/fusion/Volume_09_Modality_Combination_Analysis/01_Combination_Protocol.md): Pre-registered research questions (RQ1–RQ7), hypotheses (H1–H3), and methodological boundaries.
2. [**02_Distribution_Definition.md**](file:///d:/FusionMedAI/research/fusion/Volume_09_Modality_Combination_Analysis/02_Distribution_Definition.md): Mathematical definitions of D1, D2, D3, partition properties, sample sizes, and deterministic stratified assignment.
3. [**03_Head_Tail_Definition.md**](file:///d:/FusionMedAI/research/fusion/Volume_09_Modality_Combination_Analysis/03_Head_Tail_Definition.md): Canonical rank-based tiering (HEAD=Rank 1–2, MIDDLE=Rank 3–4, TAIL=Rank 5–7), Head-to-Tail Ratio ($HTR$).
4. [**04_Combination_Level_Metrics.md**](file:///d:/FusionMedAI/research/fusion/Volume_09_Modality_Combination_Analysis/04_Combination_Level_Metrics.md): Combination-level properties, weight distribution, routing entropy, simplex adherence.
5. [**05_Uncertainty_Analysis.md**](file:///d:/FusionMedAI/research/fusion/Volume_09_Modality_Combination_Analysis/05_Uncertainty_Analysis.md): Uncertainty scaling across cardinality, $U_{\text{sum}}$ behavior, DCRI interaction.
6. [**06_Conflict_and_Risk_Analysis.md**](file:///d:/FusionMedAI/research/fusion/Volume_09_Modality_Combination_Analysis/06_Conflict_and_Risk_Analysis.md): Conflict metrics ($\Delta_{\max}, \Delta_{\text{mean}}, \sigma_w$), risk distribution shifts across combinations.
7. [**07_Baseline_Tail_Comparison.md**](file:///d:/FusionMedAI/research/fusion/Volume_09_Modality_Combination_Analysis/07_Baseline_Tail_Comparison.md): Comparative evaluation against Baselines B1–B6, tail sensitivity $D_{\text{tail}}$, trade-off between head and tail performance.
8. [**08_Tail_Robustness.md**](file:///d:/FusionMedAI/research/fusion/Volume_09_Modality_Combination_Analysis/08_Tail_Robustness.md): Tier contrast metrics ($\Delta \sigma(R), \Delta \sigma(\text{DCRI}), \overline{\Delta R_{\text{tail}}}, \overline{\Delta \text{DCRI}_{\text{tail}}}$), sensitivity analysis.
9. [**09_Statistical_Analysis.md**](file:///d:/FusionMedAI/research/fusion/Volume_09_Modality_Combination_Analysis/09_Statistical_Analysis.md): 1,000-resample bootstrap confidence intervals ($95\%$ CI), hypothesis evaluation outcomes.
10. [**10_Results.md**](file:///d:/FusionMedAI/research/fusion/Volume_09_Modality_Combination_Analysis/10_Results.md): Comprehensive summary tables, key empirical findings, cross-distribution stability.
11. [**11_Freeze_Report.md**](file:///d:/FusionMedAI/research/fusion/Volume_09_Modality_Combination_Analysis/11_Freeze_Report.md): 20/20 verification gates, cryptographic SHA-256 manifest certification, freeze sign-off.
